-
Hengrui Medicine's SHR-1701 injection and bevacizumab injection were approved for clinical trials
Time of Update: 2021-09-12
SHR-1701 injection has carried out a number of solid tumor clinical trials in China and a phase I clinical trial in Australia .
-
Luye Pharma's "Goserelin Microspheres" Phase 3 Clinical Endpoint Reached
Time of Update: 2021-09-12
Text|Pharmaceutical Mission HillsOn September 6, Luye Pharmaceutical Group announced that its self-developed Goserelin Acetate Sustained Release Microspheres for Injection (LY01005) has completed a phase 3 clinical study for the treatment of prostate cancer in China and reached the preset end point .
-
Results of Phase 3 study of Ardelyx oral NHE3 inhibitor for effective reduction of serum phosphorus levels announced
Time of Update: 2021-09-12
In July this year, the US FDA issued a complete response letter (CRL) for tenapanor's new drug application (NDA) for CKD dialysis adult patients to control serum phosphorus levels (treatment of hyperphosphatemia) .
-
Review and Analysis of China's Pharmaceutical Industry in the "Thirteenth Five-Year Plan"-Market
Time of Update: 2021-09-12
2016-2020 China's online pharmacy drug sales and growth rate Data source: Blue Book of China's Health Industry During the "13th Five-Year Plan" period, the market structure of China's pharmaceutical industry has undergone significant changes .
-
Looking at GCP in the past to seek a future foothold in drug development
Time of Update: 2021-09-12
01 The history of GCP01 The history of GCPThe full name of GCP is Good Clinical Practice, which is a standard regulation that regulates the entire process of drug clinical trials, including plan design, organization and implementation, supervision, inspection, recording, analysis, summary, and reporting .
-
Dongyang Sun declares PD-1 monoclonal antibody biosimilars
Time of Update: 2021-09-12
This week, the eighth PD-1 in China has been approved for marketing, and the second biosimilar drug has also begun to be declared .
According to the Insight database, in addition to the approved products, there are still 32 models under development; dual antibodies are the new hotspot in research and development.
-
AstraZeneca's new generation of PARP inhibitors get clinical approval
Time of Update: 2021-09-12
On September 7, the CDE official website showed that AstraZeneca's PARP1 selective inhibitor was approved for clinical use in advanced malignant solid tumors .
Compared with AstraZeneca's listed PARP1/2 inhibitor olaparib, AZD5305 is expected to overcome the side effects of the listed PARP inhibitors .
-
Huang Wenjian, director, vice president and chief financial officer of Ogilvy Medical, resigns
Time of Update: 2021-09-12
On the evening of September 3, Ogilvy Medical announced that it had recently received a written resignation report from the company’s director, vice president and chief financial officer, Mr.
Huang Wenjian applied to resign from the position of director, vice president and chief financial officer of the company .
-
Dense layout!
Time of Update: 2021-09-11
On September 8, CDE issued a notice on the public solicitation of "Guidelines for the Design of Clinical Trials of Cetuximab Injection Biosimilar Drugs (Draft for Solicitation of Comments)" . It is
-
Development Pharmaceuticals Furitan in the treatment of androgenetic alopecia China Phase II clinical trial reached the primary endpoint
Time of Update: 2021-09-11
On September 8, Kaifeng Pharmaceutical announced that the China Phase II clinical trial of freitan (tincture) for the treatment of androgenetic alopecia has reached the primary endpoint .
-
The price of Achyranthes bidentata has risen, and the short-term benefits are hard to hide the decline in consumption!
Time of Update: 2021-09-11
Second, the price of achyranthes ushered in a wave of rise Chart: 2016-2021 market price chart of Achyranthes bidentata Beginning in 2016, the area of Achyranthes bidentata planted in surrounding villages and towns such as Chifeng Niuyingzi in Inner Mongolia continued to increase, and the output also increased .
-
Russia has developed a new method of high-precision cerebrovascular imaging
Time of Update: 2021-09-11
The new method is extremely accurate and can reconstruct blood vessel maps based on the movement of individual red blood cells without the use of toxic colorants and expensive genetic engineering techniques .
-
Renewed bids for 13 centralized procurement varieties in Wuhan, double price limit, the lowest price is planned to be selected
Time of Update: 2021-09-11
The main rules are as follows: The quotation shall not be higher than the national lowest provincial-level online price of the product of the company; it shall not be higher than the price of the original selected products in the same quality group .
-
Anti-Influenza Class 1 New Drug ADC189 Approved Clinically in China
Time of Update: 2021-09-11
Text|Pharmaceutical Mission HillsRecently, Antikang Biotechnology announced that the company's independent research and development of the company's independent research and development of the new drug ADC189 for the treatment and prevention of influenza A and B has been approved by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration.
-
PD-1, Tini Baping anti-tumor drug key monitoring, new anti-cancer drug regulations, centralized procurement and heavy punching
Time of Update: 2021-09-11
Meters within the network data show that in 2020 China's urban public hospitals , county-level public hospitals, urban community centers and township hospitals (referred to as the Chinese public medical institutions) terminal anti -tumor drug sales exceeded 100 billion yuan, an increase of 9.
-
Biotope bevacizumab injection authorized by Novartis subsidiary Sandoz
Time of Update: 2021-09-11
On September 8, Biotech announced that the company signed a licensing and commercialization agreement with Novartis’ subsidiary Sandoz AG (hereinafter referred to as “Sandoz”) to sell the company’s BAT1706 (bevacizumab) injection in the United States, The exclusive product commercialization rights in Europe, Canada and most other international markets not covered by the BAT1706 cooperation are licensed to Sandoz for a fee .
-
Zhou Xin: Solid as a rock, realizing domestically-made equipment from scratch
Time of Update: 2021-09-11
In January 2013, Zhou Xin, as a special chief scientist, took the lead in researching a major national instrument project-"Magnetic Resonance Imaging Instrument System for Research on Human Lung Diseases" .
-
Academician Chen Wei: Hearing the order, he will live up to his mission
Time of Update: 2021-09-11
Chen Wei, academician of the Chinese Academy of Engineering and researcher of the Academy of Military Medicine of the Academy of Military Sciences—— Hear the order and live up to the mission
-
Nearly 1 billion people have been vaccinated nationwide with the new coronavirus vaccine
Time of Update: 2021-09-11
Wu Liangyou, deputy director of the National Health Commission's Disease Control Bureau, introduced that the overall vaccination of people aged 12-17 in China is progressing smoothly, and 162.
-
Zhong Nanshan, Academician of the Chinese Academy of Engineering-Great doctors love to protect lives
Time of Update: 2021-09-11
Zhong Nanshan, Academician of the Chinese Academy of Engineering-Great doctors love to protect lives Zhong Nanshan, Academician of the Chinese Academy of Engineering-Great doctors l
